Bnp Paribas Asset Management Holding S.A. Sage Therapeutics, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$26.15 - $77.24 $4.9 Million - $14.5 Million	-187,284 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$60.18 - $154.77 $7.55 Million - $19.4 Million	125,534 Added 203.29%	187,284 $13.5 Million
Q3 2019 Nov 12, 2019	SELL	$140.29 - $189.96 $5.44 Million - $7.37 Million	-38,789 Reduced 38.58%	61,750 $8.66 Million
Q2 2019 Aug 02, 2019	SELL	$157.85 - $183.09 $4.15 Million - $4.81 Million	-26,274 Reduced 20.72%	100,539 $18.4 Million
Q1 2019 Apr 26, 2019	BUY	$89.33 - $163.65 $266,560 - $488,331	2,984 Added 2.41%	126,813 $20.2 Million
Q4 2018 Feb 13, 2019	BUY	$81.94 - $139.71 $2.89 Million - $4.92 Million	35,244 Added 39.79%	123,829 $11 Million
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $2 Million - $2.45 Million	14,486 Added 19.55%	88,585 $12.5 Million
Q2 2018 Aug 01, 2018	BUY	$140.36 - $175.76 $10.4 Million - $13 Million	74,099 New	74,099 $11.6 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.